Sectors
NMTC
NeuroOne Medical Technologies Corporation
1.75
1 x 1.83
2 x 2.27
bid
ask
-
0.02
1.13%
02:03 PM
timesize
| Ytd | -61.54% | |
| 1y | -61.79% |
1.62
day range
1.81
1.42
52 week range
6.96
| Open | 1.70 | Prev Close | 1.77 | Low | 1.62 | High | 1.81 | Mkt Cap | 15.94M |
| Vol | 223.47K | Avg Vol | 277.61K | EPS | -0.97 | P/E | N/A | Forward P/E | -2.65 |
| Beta | 0.61 | Short Ratio | 0.60 | Inst. Own | 19.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.29 | 200-d Avg | 3.89 | 1yr Est | 3.15 |
| Income Statement | |||
| Total Revenue | 1.97M | ||
| Revenues (USD) | 1.97M | ||
| Cost of Revenue | 790.50K | ||
| Gross Profit | 1.18M | ||
| Operating Expenses | 3.61M | ||
| Research and Development Expense | 1.43M | ||
| Selling, General and Administrative Expense | 2.18M | ||
| Operating Income | -2.42M | ||
| Net Income | -2.01M | ||
| Net Income Common Stock | -2.01M | ||
| Net Income Common Stock (USD) | -2.01M | ||
| Consolidated Income | -2.01M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -2.01M | ||
| Earning Before Interest & Taxes (USD) | -2.01M | ||
| Weighted Average Shares | 8.66M | ||
| Weighted Average Shares Diluted | 8.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.05M | ||
| Cash and Equivalents (USD) | 2.05M | ||
| Trade and Non-Trade Receivables | 1.10M | ||
| Current Assets | 5.79M | ||
| Property, Plant & Equipment Net | 369.08K | ||
| Total Assets | 6.19M | ||
| Total Debt | 73.32K | ||
| Current Liabilities | 2.04M | ||
| Debt Non-Current | 73.32K | ||
| Total Liabilities | 2.42M | ||
| Accumulated Retained Earnings (Deficit) | -84.44M | ||
| Shareholders Equity | 3.77M | ||
| Shareholders Equity (USD) | 3.77M | ||
| Assets Non-Current | 397.29K | ||
| Total Debt (USD) | 73.32K | ||
| Goodwill and Intangible Assets | 28.21K | ||
| Inventory | 2.29M | ||
| Liabilities Non-Current | 377.13K | ||
| Trade and Non-Trade Payables | 905.72K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 77.03K | ||
| Net Cash Flow from Financing | 345.03K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -756.41K | ||
| Capital Expenditure | -19.66K | ||
| Issuance (Purchase) of Equity Shares | 355.81K | ||
| Net Cash Flow from Investing | -19.66K | ||
| Net Cash Flow from Operations | -1.08M | ||
| Share Based Compensation | 352.78K | ||